Clinical Trials in Tennessee

Showing 12201-12220 of 17,345 trials

Autonomic Nervous System and Nitric Oxide Interactions

NCT01137253

The investigators are interested in the role of the autonomic nervous system in the regulation of endothelial function among obese hypertensive subjects. In particular, the investigators will study how endothelial function (response to intra-arterial acetylcholine) changes during autonomic withdrawal.

Endothelial Dysfunction

Vanderbilt University21 participantsStarted Jun 2010

Nashville, Tennessee, United States

COMPLETEDPhase 129 miles

Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents

NCT00790816

This study is designed to provide continued access to lapatinib as monotherapy or as part of a combination regimen to cancer subjects who are currently participating in a phase I trial that has met its study objectives.

Neoplasms, Breast

Novartis Pharmaceuticals500 participantsStarted Oct 2008

Scottsdale, Arizona, United States • Tucson, Arizona, United States • Santa Monica, California, United States +20 more locations

Autonomic Nervous System and Nitric Oxide Interactions

Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents

Find Trials by Condition in Tennessee

Deflazacort Expanded Access Program for Children, Adolescents and Adults With Duchenne Muscular Dystrophy

Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)

Phase I Study of CUDC-101 With Cisplatin and Radiation in Subjects With Head & Neck Cancer

Study of Safety, Tolerability, and Efficacy of Secukinumab in Subjects With Moderate to Severe Palmoplantar Psoriasis

Cardiovascular Improvements With MV ASV Therapy in Heart Failure

Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif®

Drug-drug Interaction Study of Ofatumumab With Bendamustine in Subjects With Indolent B-cell Non-Hodgkin's Lymphoma

A Phase 1 Study Evaluating CB-5083 in Subjects With Advanced Solid Tumors

A Phase 1 Study Evaluating CB-5083 in Subjects With Lymphoid Hematological Malignancies

Trebananib in Treating Patients With Persistent or Recurrent Endometrial Cancer

Extension Study of Gelesis100 on Body Weight

Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients

Phase 2 Study of Velusetrag in Diabetic or Idiopathic Gastroparesis

Treatment of Thrombocytopenia in Patients With Chronic Liver DiseaseUndergoing an Elective Procedure

A Study Evaluating MM-310 in Patients With Solid Tumors

Dropless vs. Standard Drops Contralateral Eye Study

Abatacept for Treating Adults With Giant Cell Arteritis and Takayasu's Arteritis

Chronic Hepatitis C Virus Related Thrombocytopenia to Evaluate the Effects of E5501